Cargando…
Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
[Image: see text]
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525140/ https://www.ncbi.nlm.nih.gov/pubmed/34494717 http://dx.doi.org/10.1002/cam4.4254 |
| _version_ | 1784585633476378624 |
|---|---|
| author | Foureau, David Bhutani, Manisha Guo, Fei Rigby, Katherine Leonidas, Marina Tjaden, Elise Fox, Andee Atrash, Shebli Paul, Barry Voorhees, Peter M. Usmani, Saad Z. |
| author_facet | Foureau, David Bhutani, Manisha Guo, Fei Rigby, Katherine Leonidas, Marina Tjaden, Elise Fox, Andee Atrash, Shebli Paul, Barry Voorhees, Peter M. Usmani, Saad Z. |
| author_sort | Foureau, David |
| collection | PubMed |
| description | [Image: see text] |
| format | Online Article Text |
| id | pubmed-8525140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85251402021-10-26 Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma Foureau, David Bhutani, Manisha Guo, Fei Rigby, Katherine Leonidas, Marina Tjaden, Elise Fox, Andee Atrash, Shebli Paul, Barry Voorhees, Peter M. Usmani, Saad Z. Cancer Med Clinical Cancer Researcher [Image: see text] John Wiley and Sons Inc. 2021-09-08 /pmc/articles/PMC8525140/ /pubmed/34494717 http://dx.doi.org/10.1002/cam4.4254 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Clinical Cancer Researcher Foureau, David Bhutani, Manisha Guo, Fei Rigby, Katherine Leonidas, Marina Tjaden, Elise Fox, Andee Atrash, Shebli Paul, Barry Voorhees, Peter M. Usmani, Saad Z. Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title | Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title_full | Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title_fullStr | Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title_full_unstemmed | Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title_short | Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| title_sort | comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma |
| topic | Clinical Cancer Researcher |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525140/ https://www.ncbi.nlm.nih.gov/pubmed/34494717 http://dx.doi.org/10.1002/cam4.4254 |
| work_keys_str_mv | AT foureaudavid comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT bhutanimanisha comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT guofei comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT rigbykatherine comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT leonidasmarina comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT tjadenelise comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT foxandee comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT atrashshebli comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT paulbarry comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT voorheespeterm comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma AT usmanisaadz comparisonofmassspectrometryandflowcytometryinmeasuringminimalresidualdiseaseinmultiplemyeloma |